Lobbyist Insight

Colorado · 2022-2023

SB22-186

Create Colorado Rare Disease Advisory Council

Read SB22-186 at the Colorado legislature →

29 registered positions on this bill · 29 state a side.

Lobbyist or firmFor clientPositionSession
Rodriguez, Luis Armando IIIAlexion Pharmaceuticals, Inc.Supporting2021-2022
Miller, PaulAstellas Pharma US, Inc.Supporting2021-2022
OnTheBallot ConsultingAstellas Pharma US, Inc.Supporting2021-2022
Aponte Public Affairs, Inc.Aveanna HealthcareMonitoring2021-2022
Wagner Morgan Strategies, LLCBiogen MA Inc.Supporting2021-2022
Stern, Ellen SteinerChildren's Hospital ColoradoSupporting2021-2022
Stern, Ellen SteinerChildren's Hospital ColoradoAmending2021-2022
Colorado Legislative StrategiesColorado BioScience AssociationSupporting2021-2022
Crews, Michael AnthonyColorado BioScience AssociationSupporting2021-2022
Aponte Public Affairs, Inc.Colorado Radiological Society (CRS)Monitoring2021-2022
Aponte Public Affairs, Inc.Colorado Society of Anesthesiologists (CSA)Monitoring2021-2022
Aponte Public Affairs, Inc.Colorado Society of Anesthesiology (CSA)Monitoring2021-2022
Aponte Public Affairs, Inc.Colorado Society of Oral & Maxillofacial Surgeons (CSOMS)Monitoring2021-2022
Paredes, Richard MichaelGENENTECH, INC., A MEMBER OF THE ROCHE GROUPSupporting2021-2022
Capitol Focus, LLCGenentech, A member of the Roche GroupSupporting2021-2022
The Capstone Group, LLCGilead Sciences, IncMonitoring2021-2022
Axiom Strategies Inc dba Axiom PoliticsHorizon TherapeuticsMonitoring2021-2022
HB StrategiesHorizon TherapeuticsMonitoring2021-2022
Capitol Focus, LLCJohnson & JohnsonMonitoring2021-2022
Aponte Public Affairs, Inc.MednaxMonitoring2021-2022
Patel, AlyssNORD - National Organization for Rare Disorders, Inc.Supporting2022-2023
Reed, AnnissaNORD - National Organization for Rare Disorders, Inc.Supporting2021-2022
Axiom Strategies Inc dba Axiom PoliticsNeurocrineMonitoring2021-2022
HB StrategiesNeurocrineMonitoring2021-2022
CHRISTENSEN-BONER, BARBARANovartis Services, Inc.Supporting2021-2022
BRANDEBERRY MCKENNA PUBLIC AFFAIRSPfizerSupporting2021-2022
DeWolf, ZoeySanofi USMonitoring2021-2022
Aponte Public Affairs, Inc.Vertex Pharmaceuticals Inc.Supporting2021-2022
Aponte Public Affairs, Inc.Vertex Pharmceuticals Inc.Supporting2021-2022

Positions are as filed. A lobbyist may file more than once as a position changes.